Annual EBITDA
$323.60 M
+$214.60 M+196.88%
31 December 2023
Summary:
Insulet annual earnings before interest, taxes, depreciation & amortization is currently $323.60 million, with the most recent change of +$214.60 million (+196.88%) on 31 December 2023. During the last 3 years, it has risen by +$184.00 million (+131.81%). PODD annual EBITDA is now at all-time high.PODD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$116.50 M
+$35.20 M+43.30%
30 September 2024
Summary:
Insulet quarterly earnings before interest, taxes, depreciation & amortization is currently $116.50 million, with the most recent change of +$35.20 million (+43.30%) on 30 September 2024. Over the past year, it has dropped by -$16.80 million (-12.60%). PODD quarterly EBITDA is now -12.60% below its all-time high of $133.30 million, reached on 31 December 2023.PODD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$415.50 M
+$33.70 M+8.83%
30 September 2024
Summary:
Insulet TTM earnings before interest, taxes, depreciation & amortization is currently $415.50 million, with the most recent change of +$33.70 million (+8.83%) on 30 September 2024. Over the past year, it has increased by +$91.90 million (+28.40%). PODD TTM EBITDA is now at all-time high.PODD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PODD EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -12.6% | +28.4% |
| 3 y3 years | +131.8% | +76.3% | +197.6% |
| 5 y5 years | +336.1% | +346.4% | +460.0% |
PODD EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +196.9% | -12.6% | +1054.9% | at high | +293.5% |
| 5 y | 5 years | at high | +336.1% | -12.6% | +1054.9% | at high | +460.0% |
| alltime | all time | at high | +532.6% | -12.6% | +628.3% | at high | +655.5% |
Insulet EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $116.50 M(+43.3%) | $415.50 M(+8.8%) |
| June 2024 | - | $81.30 M(-3.7%) | $381.80 M(+7.0%) |
| Mar 2024 | - | $84.40 M(-36.7%) | $356.80 M(+10.3%) |
| Dec 2023 | $323.60 M(+196.9%) | $133.30 M(+61.0%) | $323.60 M(+36.3%) |
| Sept 2023 | - | $82.80 M(+47.1%) | $237.50 M(+36.4%) |
| June 2023 | - | $56.30 M(+10.0%) | $174.10 M(+64.9%) |
| Mar 2023 | - | $51.20 M(+8.5%) | $105.60 M(-1.2%) |
| Dec 2022 | $109.00 M(-21.9%) | $47.20 M(+143.3%) | $106.90 M(-15.0%) |
| Sept 2022 | - | $19.40 M(-259.0%) | $125.80 M(-17.0%) |
| June 2022 | - | -$12.20 M(-123.2%) | $151.60 M(-8.8%) |
| Mar 2022 | - | $52.50 M(-20.6%) | $166.20 M(+19.1%) |
| Dec 2021 | $139.60 M(+26.6%) | $66.10 M(+46.2%) | $139.60 M(+50.6%) |
| Sept 2021 | - | $45.20 M(+1783.3%) | $92.70 M(+11.7%) |
| June 2021 | - | $2.40 M(-90.7%) | $83.00 M(-30.3%) |
| Mar 2021 | - | $25.90 M(+34.9%) | $119.00 M(+7.9%) |
| Dec 2020 | $110.30 M(+48.7%) | $19.20 M(-45.9%) | $110.30 M(-5.9%) |
| Sept 2020 | - | $35.50 M(-7.6%) | $117.20 M(+18.0%) |
| June 2020 | - | $38.40 M(+123.3%) | $99.30 M(+31.2%) |
| Mar 2020 | - | $17.20 M(-34.1%) | $75.70 M(+2.0%) |
| Dec 2019 | $74.20 M(+57.5%) | $26.10 M(+48.3%) | $74.20 M(+6.7%) |
| Sept 2019 | - | $17.60 M(+18.9%) | $69.51 M(+8.5%) |
| June 2019 | - | $14.80 M(-5.7%) | $64.08 M(+10.0%) |
| Mar 2019 | - | $15.70 M(-26.7%) | $58.25 M(+22.0%) |
| Dec 2018 | $47.10 M(+635.9%) | $21.41 M(+76.1%) | $47.75 M(+74.6%) |
| Sept 2018 | - | $12.16 M(+35.5%) | $27.34 M(+26.5%) |
| June 2018 | - | $8.97 M(+72.4%) | $21.61 M(+64.3%) |
| Mar 2018 | - | $5.20 M(+416.3%) | $13.15 M(+105.5%) |
| Dec 2017 | $6.40 M(+356.2%) | $1.01 M(-84.3%) | $6.40 M(+29.8%) |
| Sept 2017 | - | $6.43 M(+1150.8%) | $4.93 M(+123.2%) |
| June 2017 | - | $514.00 K(-133.1%) | $2.21 M(-44.2%) |
| Mar 2017 | - | -$1.55 M(+236.4%) | $3.96 M(+182.2%) |
| Dec 2016 | $1.40 M(-104.3%) | -$461.00 K(-112.4%) | $1.40 M(-122.1%) |
| Sept 2016 | - | $3.71 M(+63.7%) | -$6.34 M(-69.1%) |
| June 2016 | - | $2.26 M(-155.1%) | -$20.53 M(-38.1%) |
| Mar 2016 | - | -$4.11 M(-49.9%) | -$33.14 M(+0.9%) |
| Dec 2015 | -$32.84 M(+55.8%) | -$8.20 M(-21.8%) | -$32.84 M(+60.7%) |
| Sept 2015 | - | -$10.48 M(+1.3%) | -$20.43 M(+39.3%) |
| June 2015 | - | -$10.35 M(+171.9%) | -$14.66 M(-44.4%) |
| Mar 2015 | - | -$3.81 M(-190.4%) | -$26.36 M(+25.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | -$21.08 M(+30.3%) | $4.21 M(-189.3%) | -$21.08 M(+1.6%) |
| Sept 2014 | - | -$4.71 M(-78.6%) | -$20.75 M(-31.4%) |
| June 2014 | - | -$22.05 M(-1590.1%) | -$30.23 M(+164.6%) |
| Mar 2014 | - | $1.48 M(-67.4%) | -$11.42 M(-29.4%) |
| Dec 2013 | -$16.18 M(-34.8%) | $4.54 M(-132.0%) | -$16.18 M(-32.1%) |
| Sept 2013 | - | -$14.19 M(+336.5%) | -$23.84 M(+53.9%) |
| June 2013 | - | -$3.25 M(-0.7%) | -$15.49 M(-22.9%) |
| Mar 2013 | - | -$3.27 M(+4.9%) | -$20.08 M(-19.1%) |
| Dec 2012 | -$24.83 M(-26.6%) | -$3.12 M(-46.6%) | -$24.83 M(-15.5%) |
| Sept 2012 | - | -$5.85 M(-25.4%) | -$29.37 M(-3.5%) |
| June 2012 | - | -$7.84 M(-2.3%) | -$30.43 M(-15.0%) |
| Mar 2012 | - | -$8.02 M(+4.7%) | -$35.78 M(+5.8%) |
| Dec 2011 | -$33.83 M(+1.3%) | -$7.66 M(+11.0%) | -$33.83 M(-2.2%) |
| Sept 2011 | - | -$6.90 M(-47.7%) | -$34.59 M(-0.4%) |
| June 2011 | - | -$13.19 M(+117.2%) | -$34.72 M(+15.1%) |
| Mar 2011 | - | -$6.07 M(-27.9%) | -$30.17 M(-9.6%) |
| Dec 2010 | -$33.39 M(-38.1%) | -$8.43 M(+19.9%) | -$33.39 M(-5.8%) |
| Sept 2010 | - | -$7.03 M(-18.7%) | -$35.46 M(-12.5%) |
| June 2010 | - | -$8.64 M(-7.0%) | -$40.54 M(-13.8%) |
| Mar 2010 | - | -$9.29 M(-11.5%) | -$47.02 M(-12.8%) |
| Dec 2009 | -$53.90 M(-27.9%) | -$10.50 M(-13.3%) | -$53.90 M(-12.3%) |
| Sept 2009 | - | -$12.11 M(-19.9%) | -$61.47 M(-8.8%) |
| June 2009 | - | -$15.12 M(-6.5%) | -$67.41 M(-6.8%) |
| Mar 2009 | - | -$16.17 M(-10.5%) | -$72.37 M(-3.2%) |
| Dec 2008 | -$74.80 M(+52.9%) | -$18.07 M(+0.1%) | -$74.80 M(+4.8%) |
| Sept 2008 | - | -$18.05 M(-10.1%) | -$71.39 M(+7.3%) |
| June 2008 | - | -$20.07 M(+8.0%) | -$66.53 M(+15.4%) |
| Mar 2008 | - | -$18.60 M(+26.8%) | -$57.63 M(+17.8%) |
| Dec 2007 | -$48.92 M(+52.9%) | -$14.66 M(+11.2%) | -$48.92 M(+14.6%) |
| Sept 2007 | - | -$13.19 M(+18.0%) | -$42.69 M(+9.4%) |
| June 2007 | - | -$11.18 M(+13.0%) | -$39.04 M(+43.6%) |
| Mar 2007 | - | -$9.89 M(+17.3%) | -$27.19 M(+63.6%) |
| Dec 2006 | -$32.01 M(+57.9%) | -$8.44 M(-11.5%) | -$16.62 M(+103.1%) |
| Sept 2006 | - | -$9.53 M(-1514.4%) | -$8.19 M(-707.2%) |
| June 2006 | - | $674.00 K(0.0%) | $1.35 M(+100.0%) |
| Mar 2006 | - | $674.00 K | $674.00 K |
| Dec 2005 | -$20.27 M(+46.6%) | - | - |
| Dec 2004 | -$13.83 M(+15.1%) | - | - |
| Dec 2003 | -$12.01 M(-5.2%) | - | - |
| Dec 2002 | -$12.67 M | - | - |
FAQ
- What is Insulet annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Insulet?
- What is Insulet quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Insulet?
- What is Insulet quarterly EBITDA year-on-year change?
- What is Insulet TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Insulet?
- What is Insulet TTM EBITDA year-on-year change?
What is Insulet annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of PODD is $323.60 M
What is the all time high annual EBITDA for Insulet?
Insulet all-time high annual earnings before interest, taxes, depreciation & amortization is $323.60 M
What is Insulet quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of PODD is $116.50 M
What is the all time high quarterly EBITDA for Insulet?
Insulet all-time high quarterly earnings before interest, taxes, depreciation & amortization is $133.30 M
What is Insulet quarterly EBITDA year-on-year change?
Over the past year, PODD quarterly earnings before interest, taxes, depreciation & amortization has changed by -$16.80 M (-12.60%)
What is Insulet TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of PODD is $415.50 M
What is the all time high TTM EBITDA for Insulet?
Insulet all-time high TTM earnings before interest, taxes, depreciation & amortization is $415.50 M
What is Insulet TTM EBITDA year-on-year change?
Over the past year, PODD TTM earnings before interest, taxes, depreciation & amortization has changed by +$91.90 M (+28.40%)